维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="SZUCS TD"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Influenza vaccination coverage rates in five European countries-a population based cross sectional analysis of two consecutive influenza seasons显示文摘	Szucs TD Muller D	2005	Vaccine2005，43，9：	1
2	A systematic review of the cost effectiveness ofherpes zoster vaccination 显示文摘	Szucs TD Pfeil AM	2013	Pharmacoeconomics2013，31，2：	1
3	Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective显示文摘	Szucs TD Waeber B Tomonaga Y	2009	J Hum Hypertens2009，，：	1
4	Economic aspects of travelers'diarrhea显示文摘	Wang M Szucs TD ?Steffen R	2008	J Travel Med2008，15，2：	1
5	Reducing the burden of influenza-associated complications with antiviral therapy 显示文摘	Ruf BR Szucs TD	2009	Infection2009，37，3：	1
6	European healthcare policies for controlling drug expenditure 显示文摘	Ess SM Schneeweiss S Szucs TD	2003	Pharmacoeconomics2003，21，2：	1
7	Management and costs of treating lung cancer patients in a university hospital显示文摘	Dedes KJ Szucs TD Bodis S	2004	Pharmacoeconomics2004，22，7：	1
8	European healthcare policies for controlling drug expenditure显示文摘	Ess SM Schneeweiss S Szucs TD	2003	Pharmacoeco- nomics2003，21，2：	1
9	European healthcare policies for controlling drug expenditure 显示文摘	ESS SM SCHNEEWEISS S SZUCS TD	2003	Pharmacoeconom- ics2003，21，2：	1
10	The cost effectiveness of low molecular weight heparin vs unfractionated heparin in general and orthopaedic surgery:an analysis for the German healthcare system显示文摘	Szucs TD Schramm W	1999	Pharmacol Res1999，40，1：	1
11	Cost effectiveness of clopidogrel in secondary cardiovascular prevention:a cost-effectiveness analysis based on the Caprie Study显示文摘	Haldemann R Luscher TF Szucs TD	2001	Schweiz Rundsch Med Prax2001，90，13：	1
12	Health economic research on vaccinations and immunisation practices--an introductory primer显示文摘	Szucs TD	2005	Vaccine2005，23，1718：	1
13	Cost of treating to a modified european atherosclerosis society LDL-C target:comparison of atorvastatin with fluvastatin,pravastatin and simvastatin显示文摘	Smith DG Leslie SJ Szucs TD	1999	Clinical Drug Investigation1999，17，3：	1
14	Influenza:the role of burden-of-illness research显示文摘	Szucs TD	1999	Pharmacoecono Mics1999，16，1：	1
15	The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland - an analysis of the RENAAL study显示文摘	Szucs TD Sandoz MS Keusch GW	2004	Swiss Med Wkly2004，134，：	1
16	Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma:data from the INC-EU Prospective Observational European Neutropenia Study显示文摘	Pettengell R Bosly A Szucs TD	2009	Br J Haematol2009，144，：	1
17	Economic assessment of tirofiban in the management of acute coronary syndromes in the hospital setting: an analysis based on the PRISM PLUS trial 显示文摘	Szucs TD Meyer BJ Kiowski W	1999	Eur Heart J1999，20，：	1
18	Stroke in Switzerland: social determinants of treatment access and cost of illness 显示文摘	Snozzi P Blank PR Szucs TD	2014	Journal of stroke and eerebrovascular diseases:the official journal of National Stroke Association2014，23，5：	1
19	Medical - economical aspects of high- sensitivity C- reactive protein assay for the prediction of coronary heart disease: An analysis in Germany and Italy显示文摘	Ess SM Szucs TD	2001	Ital Heart J2001，2，3：	1
20	Hodgkin lymphoma treatment with ABVD in the US and the EU:neutropenia occurrence and impaired chemotherapy delivery显示文摘	Schwenkglenks M Pettengell R Szucs TD	2010	J Hematol Oncol2010，3，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示